Table-II.
The distribution of blood and blood products transfusion cases by case type, product qualities, and age (n=11).
| Case Type | Blood Product | Age | % |
|---|---|---|---|
| Excessive transfusion | Human albumin | 1 | 9 |
| Higher amount of transfusion | Erythrocyte suspension | 1 | |
| Higher amount of transfusion | Erythrocyte suspension | 5 | |
| Lower amount of transfusion | Erythrocyte suspension | 2 | 45.4 |
| Higher amount of transfusion | Erythrocyte suspension | 2 | |
| Higher amount of transfusion | Erythrocyte suspension | 1 | |
| Immunological hemolysis due to alloantibody | Erythrocyte suspension | 2 | 18.5 |
| Immunological hemolysis due to ABO incompatibility | Erythrocyte suspension | 1 | |
| Anaphylaxis /excessive sensitivity red cells Anaphylaxis | Fresh frozen plasma | 8 | 18.5 |
| Fresh frozen plasma | 3 | ||
| Blood product being prepared with missing ingredient (without apheresis) | Thrombocyte suspension | 14 | 9 |
| Total | 11 | 100 | |